Certified by Founder Lodge
AMILI
Singapore - Central Singapore
START UP
1 Disclosed Funding Rounds $10,500,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AMILI is a precision gut microbiome company based in Singapore serving the region.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 15 ,2022 | Series A | $10,500,000 |
SEEDS Capital
Capital Code
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
